Trump’s justification for the tariffs was rebalancing the trade deficit—it’s not going the way he wanted

December BEA data show the U.S. goods and services deficit widened to $70.3 billion, up $17.3 billion from November as imports rose 3.6% to $357.6 billion and exports fell to $287.3 billion. Services surplus narrowed to $29 billion and industrial supplies/materials saw an $8.7 billion deterioration while, on an annual basis, the 2025 deficit edged down $2.1 billion (0.2%) versus 2024. Notably, the U.S. deficit with China plunged $93.4 billion to $202.1 billion as imports from China fell $130.4 billion, reflecting accelerating trade redirection and geopolitical-driven decoupling despite ongoing tariff-driven tensions and policy moves from the Trump administration.

Analysis

Market structure: The December $70.3bn monthly goods & services deficit (imports $357.6bn, exports $287.3bn) reallocates surplus/power to domestic producers who can substitute imports — primarily defense (LMT/NOC/RTX), semiconductor equipment (LRCX/AMAT), specialty chemicals and miners (FCX) — while import-heavy retailers and consumer electronics OEMs face margin pressure. China-specific redirection is acute: bilateral deficit with China fell ~$93bn to $202.1bn and China’s share of U.S. imports dropped to ~7% from 13% in 2024, implying near-term dislocation and multi-year capex to re-shore capacity.

Risk assessment: Tail risks include rapid escalation to sweeping embargoes or Chinese retaliatory tariffs causing commodity shocks (oil, copper up >15% in 30 days) or a painful consumer slowdown forcing Fed to pivot. Immediate (days) risk: headline-driven volatility around tariff announcements; short-term (3–9 months): supply-chain reroutes and margin squeeze; long-term (1–3 years): structural capex cycles and higher domestic input costs. Hidden dependency: many U.S. firms still rely on Chinese intermediates — apparent import declines can mask inventory drawdowns.

Trade implications: Prioritize 6–18 month exposure to domestic-capex beneficiaries and defensive cyclicals: establish 2–3% long positions in LRCX and AMAT (fab-equipment) and 1–2% long in LMT, targeting 15–30% upside on successful reshoring announcements; reduce/short 2–3% positions in WMT/TGT or buy XRT puts for 3–6 months as import-led margin pressure persists. Use options: buy AMAT 6–9 month 20–25% OTM call spreads to cap cost; buy XRT 3-month puts or collar WMT holdings.

Contrarian angles: Markets may be pricing permanent decoupling too quickly — China still likely to retain >10% share absent full bans, creating mean-reversion opportunities in Chinese exporters and shipping (over-sold); historical parallel: 2018 tariffs produced short-term disruption but trade volumes normalized within ~18 months. Watch unintended consequences: persistent tariff inflation could force tighter Fed policy, which would hurt long-duration growth names and re-rate the capex trade if yields rise >100bp.

Key Decisions for Investors

• Establish a 2–3% portfolio long in LRCX and a 2% position in AMAT (equal-weight) with a 6–18 month horizon; target +15–30% upside on confirmed U.S. reshoring contracts or fab announcements, stop-loss at -12%.
• Initiate a 2% long in LMT (defense prime) for 12–24 months to capture procurement/stockpile re-shoring; trim on +20% or if FY guidance misses by >5%.
• Short/underweight 2–3% in high-import retailers (WMT, TGT) or buy XRT 3–6 month puts if monthly imports remain >$350bn or retail margins compress >50bp quarter-over-quarter; set profit target at 20% on option position.
• Buy AMAT 6–9 month call spreads (buy 25% OTM, sell 50% OTM) sized to 0.5–1% portfolio risk to play capex visibility while capping premium; roll on material tariff/reshoring headlines.
• Monitor three actionable triggers over next 90 days: (1) U.S. import level >$360bn or < $340bn (trade momentum), (2) China share of imports crossing 10% (reversal signal), and (3) two consecutive months of corporate capex guide-ups — take profits or re-allocate when triggers change direction.